Evidence map›Paper›PMID 40838680›Full record

ArticleRadiation protection dosimetry2025

Comparing dose response of cancer incidence in Sweden after the Chernobyl Nuclear Power Plant accident with Life Span Study of atomic bomb survivors.

Martin Tondel, Tobias Nordquist, Mats Isaksson, Christopher Rääf, Robert Wålinder

Abstract readComparative Study
In one paragraph

Article in Radiation protection dosimetry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Martin TondelOccupational and Environmental Medicine, Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Entrance 40, SE-751 85 Uppsala, Sweden.ORCID 0000-0003-4469-2451
Tobias NordquistDepartment of Occupational and Environmental Medicine, Uppsala University Hospital, Dag Hammarskjölds väg 60, SE-751 85 Uppsala, Sweden.
Mats IsakssonDepartment of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gula Stråket 2B, SE-413 45, Gothenburg, Sweden.ORCID 0000-0001-9854-5030
Christopher RääfMedical Radiation Physics, Department of Translational Medicine, Lund University, Inga Marie Nilssons gata 47, SE-205 02 Malmö, Sweden.ORCID 0000-0002-9495-7166
Robert WålinderOccupational and Environmental Medicine, Department of Medical Sciences, Uppsala University, Uppsala University Hospital, Entrance 40, SE-751 85 Uppsala, Sweden.ORCID 0000-0002-8387-7881

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Follow-up of the atomic bomb survivors in Japan in the Life Span Study (LSS) has been fundamental for the understanding of the dose-response curve. We compare our risk estimates from a newly published epidemiological study on cancer in Sweden after the Chernobyl Nuclear Power Plant accident with the LSS data. Hazard ratios (HRs) with 95% confidence intervals (95% CIs) were calculated using conditional logistic regression adjusted for rural/nonrural habitat, education level, and pre-Chernobyl cancer incidence from 1980 to 1985, respectively. Adjusted HRs by sex were calculated in deciles for all cancer sites combined for 1986 to 2020. These risk estimates were translated to excess relative risk (ERR) to allow comparison with LSS incidence data. ERRs per decile were compatible with ERR in the low-dose range <100 mGy for both sexes. The CIs in each decile need to be taken into account when interpreting the dose-response curve. Risk estimates in dose categories add important information at very low doses on the dose-response curve when compared to LSS data.

Indexed as

Atomic Bomb SurvivorsChernobyl Nuclear AccidentNeoplasms, Radiation-InducedAdolescentAdultAgedAged, 80 and overChildChild, PreschoolDose-Response Relationship, RadiationFemaleHumansIncidenceInfantMaleMiddle Aged

Identifiers

PMID40838680
PMCPMC12498092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.